These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9728587

  • 21. Adjuvant chemotherapy for non-small-cell lung cancer.
    Pisters KM.
    Clin Adv Hematol Oncol; 2003 Sep; 1(9):533-7. PubMed ID: 16258445
    [Abstract] [Full Text] [Related]

  • 22. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A, Genestreti G, Fiorio E, Terzi A, Lonardoni A, Calabrò F, Campaldini B, Colaluca P, Molino A, Cetto GL.
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED, Herbert SM, Hanna NH.
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [Abstract] [Full Text] [Related]

  • 24. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N, Shepherd FA, Winton T, Graham B, Johnson D, Livingston R, Rigas J, Whitehead M, Ding K, Seymour L.
    Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522
    [Abstract] [Full Text] [Related]

  • 25. The role of adjuvant chemotherapy for non-small cell lung cancer.
    Gurubhagavatula S, Lynch TJ.
    Semin Respir Crit Care Med; 2005 Jun; 26(3):298-303. PubMed ID: 16052431
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger S, Schlemmer M, Heinemann V, Stemmler HJ.
    Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
    [Abstract] [Full Text] [Related]

  • 27. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H.
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [Abstract] [Full Text] [Related]

  • 28. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology.
    J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K, Matsuo K, Kiura K, Ueoka H, Tanimoto M.
    Curr Opin Oncol; 2006 Mar 01; 18(2):144-50. PubMed ID: 16462183
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
    de Boer RH, Smith IE, Pastorino U, O'Brien ME, Ramage F, Ashley S, Goldstraw P.
    Br J Cancer; 1999 Mar 01; 79(9-10):1514-8. PubMed ID: 10188899
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M, Rolland E, Pignon JP, Seymour L, Ding K, Tribodet H, Winton T, Le Chevalier T, Scagliotti GV, Douillard JY, Spiro S, Shepherd FA.
    J Clin Oncol; 2008 Jul 20; 26(21):3573-81. PubMed ID: 18640938
    [Abstract] [Full Text] [Related]

  • 35. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766
    [Abstract] [Full Text] [Related]

  • 36. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
    Dediu M, Horvat T, Tarlea A, Anghel R, Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C, Savu C.
    Lung Cancer; 2005 Jan 01; 47(1):93-101. PubMed ID: 15603859
    [Abstract] [Full Text] [Related]

  • 37. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF, Schildermans RH.
    Expert Rev Anticancer Ther; 2005 Feb 01; 5(1):165-75. PubMed ID: 15757448
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y, Tanaka F, Wada H, Hitomi S.
    Gan To Kagaku Ryoho; 1997 Aug 01; 24(10):1245-51. PubMed ID: 9279343
    [Abstract] [Full Text] [Related]

  • 40. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 01; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.